4D Molecular Therapeutics, Inc.
FDMT
$4.11
-$0.17-3.97%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.41% | 57.01% | 74.63% | 162.36% | 34.97% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.33% | 3.33% | 43.78% | 46.95% | 20.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 46.65% | 55.60% | 73.91% | 158.69% | 34.50% |
|
|
|||||
| Total Current Assets | 46.65% | 55.60% | 73.91% | 158.69% | 34.50% |
| Net Property, Plant & Equipment | 28.24% | 27.35% | -12.48% | -10.88% | -10.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 522.95% | 319.94% | 114.81% | -38.81% | -36.67% |
| Total Assets | 64.87% | 67.04% | 75.92% | 158.13% | 29.81% |
|
|
|||||
| Total Accounts Payable | 24.78% | -37.96% | -1.77% | 75.12% | 5.81% |
| Total Accrued Expenses | 57.06% | 110.07% | 94.25% | 66.48% | 35.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 79.01% | 62.86% | 3.00% | 18.48% | 18.61% |
| Total Finance Division Other Current Liabilities | -5.86% | -73.08% | -- | -- | -69.12% |
| Total Other Current Liabilities | -5.86% | -73.08% | -- | -- | -69.12% |
| Total Current Liabilities | 53.81% | 62.23% | 41.12% | 45.44% | 20.47% |
|
|
|||||
| Total Current Liabilities | 53.81% | 62.23% | 41.12% | 45.44% | 20.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 64.63% | 64.10% | -16.50% | -15.43% | -14.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.47% | 26.06% | 76.73% | 69.79% | 21.39% |
| Total Liabilities | 55.26% | 61.24% | 16.15% | 15.38% | 5.09% |
|
|
|||||
| Common Stock & APIC | 50.26% | 51.37% | 53.57% | 86.53% | 32.20% |
| Retained Earnings | -38.73% | -37.46% | -29.48% | -30.47% | -32.06% |
| Treasury Stock & Other | 1,331.25% | 102.06% | -184.93% | 59.63% | 101.34% |
| Total Common Equity | 65.87% | 67.59% | 80.95% | 174.72% | 33.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 65.87% | 67.59% | 80.95% | 174.72% | 33.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 65.87% | 67.59% | 80.95% | 174.72% | 33.07% |
|
|
|||||
